Patient-Derived Xenograft (PDX) Tumor Microarrays (TMAs)
Enhancing Cancer Research with High-Throughput PDX TMAs
At Crown Bioscience, our Patient-Derived Xenograft (PDX) Tumor Microarrays (TMAs) offer researchers a powerful tool for cancer research, enabling high-throughput analysis of various cancer types. Our PDX TMAs provide an extensive array of tissue samples crucial for biomarker validation, drug target discovery, and translational research.
